The U.S. Food and Drug Administration issued final guidance Thursday aimed at improving how pregnancy safety data is collected for drugs and biological products after they are approved. The guidance, ...
The US Food and Drug Administration (FDA) is working on ways to facilitate greater use of real-world data (RWD) to help understand the safety and efficacy of medications used during pregnancy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results